Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc. (NYSE: CLS; TSX: CLS) is back in the spotlight on December 15, 2025 after a sharp pullback that reminded investors of an uncomfortable truth: even “AI infrastructure winners” can get whipsawed when the market mood flips. On the NYSE, Celestica closed at $306.50 on December 12, down $44.91 (-12.78%), and was indicated higher in early pre-market trading on December 15 around $312.10 (+1.83%). StockAnalysis So what’s driving the move, what’s new in today’s news flow, and what do forecasts look like heading into 2026? Why Celestica stock dropped: the selloff was bigger than one company The most important
15 December 2025
·
ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Integrated Shipping Services Ltd. stock is back in the spotlight on Dec. 15, 2025, caught at the intersection of three forces that can yank any shipping name around: freight-rate expectations, corporate control drama, and the always-contentious question of how much cash a cyclical carrier should return to shareholders. As of the latest available trading update, ZIM shares were around $18.76, down about 5.4% from the prior close—an intraday move that underscores how headline-sensitive the stock has become as takeover speculation heats up and a high-stakes shareholder vote approaches. ZIM Investors Why ZIM stock is moving now: M&A rumors collide
15 December 2025
···
Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) entered a new phase in its corporate life this month: from clinical-stage story stock to a company with an FDA-approved, commercially launchable cardiovascular product. The catalyst is CARDAMYST™ (etripamil) nasal spray, now approved in the U.S. for adults experiencing acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT)—a rapid heart rhythm disturbance that can be frightening, disruptive, and costly when it sends patients to emergency care. GlobeNewswire Yet in classic biotech fashion, the stock market’s reaction has been anything but simple. Despite the “yes” from regulators, MIST shares saw sharp volatility into the weekend, and investors
15 December 2025
·
GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace stock is back in the market’s spotlight heading into mid-December, trading around $299.81 and up roughly 4% versus the prior close in the latest available quote. That move isn’t happening in a vacuum. Over the past several days, GE has landed fresh bullish Wall Street coverage, surfaced in defense-related headlines, and found itself indirectly tied to a regulatory development affecting the CFM LEAP engine family—one of the most important programs in modern commercial aviation. Below is what’s driving GE Aerospace stock right now, how analysts are framing upside (and limits), and what investors will be watching as GE
15 December 2025
···
Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron Technology, Inc. (NASDAQ: MU) heads into mid-December with one big, market-moving catalyst: its fiscal first-quarter 2026 earnings report and conference call on Wednesday, Dec. 17, 2025. Micron Technology+1 After an explosive 2025 run—Micron shares have gained more than 200% year-to-date in some tallies—investors are now trying to answer a more delicate question: Is MU still in the early innings of an “AI memory supercycle,” or are expectations so high that even good results could trigger a sell-the-news reaction? Investopedia As of the latest available quote in this briefing, MU is around $241.14, which implies a roughly 6.7% drop versus
15 December 2025
··
Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare Inc. (NASDAQ: IXHL) is back on traders’ radar heading into mid-December, with the stock hovering around $0.42 in early Monday pricing on December 15, 2025, after closing near $0.40 in the prior session. The renewed attention isn’t coming out of nowhere. Over the past several weeks, Incannex has stacked up a series of developments that matter to speculative biotech investors: a U.S. FDA Fast Track designation for its lead obstructive sleep apnea (OSA) program, a Nasdaq minimum bid-price compliance deadline now pushed into 2026, and fresh research commentary from at least one boutique coverage firm—along with a mixed
15 December 2025
·
ImmunityBio (IBRX) Stock in Focus on Dec. 15, 2025: EMA’s ANKTIVA Nod, Analyst Targets, and What Comes Next

ImmunityBio (IBRX) Stock in Focus on Dec. 15, 2025: EMA’s ANKTIVA Nod, Analyst Targets, and What Comes Next

December 15, 2025 — ImmunityBio, Inc. (NASDAQ: IBRX) is back on investors’ radar today as fresh coverage and new analysis dig into a major European regulatory milestone for its lead therapy ANKTIVA (nogapendekin alfa inbakicept). The market’s obsession is simple: does this become the catalyst that turns ImmunityBio into a real commercial oncology story—or just the latest biotech pop before the harder work of reimbursement, uptake, and cash management begins? Below is a complete, publication-ready roundup of the news, forecasts, and market analysis circulating on December 15, 2025, plus the key fundamentals investors are weighing right now. Why ImmunityBio stock
15 December 2025
··
Oklo Inc Stock (OKLO) on Dec. 15, 2025: Latest News, $1.5B ATM Offering, Analyst Forecasts, and What Investors Are Watching

Oklo Inc Stock (OKLO) on Dec. 15, 2025: Latest News, $1.5B ATM Offering, Analyst Forecasts, and What Investors Are Watching

December 15, 2025 — Oklo Inc. (NYSE: OKLO) is starting the week with investors trying to separate two very different stories that have become tangled together: the long, regulated march toward advanced nuclear deployment, and the short, adrenaline-fueled “AI infrastructure” trade that just took a hit. The immediate backdrop is brutal volatility. OKLO closed at $87.42 on Friday, Dec. 12, down about 15% on the day after trading as high as roughly $103 earlier in the session. StockAnalysis+1 That selloff came as markets rotated away from AI-linked names on renewed “AI bubble” jitters—Oklo was explicitly called out among the AI-infrastructure
15 December 2025
·
cbdMD (YCBD) Stock News Today (Dec. 15, 2025): Why Shares Are Volatile, What the Latest Filings Say, and the Updated YCBD Stock Forecast

cbdMD (YCBD) Stock News Today (Dec. 15, 2025): Why Shares Are Volatile, What the Latest Filings Say, and the Updated YCBD Stock Forecast

December 15, 2025 — cbdMD, Inc. (NYSE American: YCBD) is back on traders’ radars after a sharp, high-volume move that has turned this micro-cap wellness name into one of the most talked-about tickers in the hemp and cannabis-adjacent space this week. The rally is being fueled by a mix of company-specific catalysts (exchange compliance + preliminary FY2025 results) and sector-wide momentum tied to Washington policy headlines. PR Newswire+2PR Newswire+2 Below is a full roundup of the latest cbdMD stock news, key SEC details, what management has already guided for fiscal 2025, and where the current YCBD stock forecast stands as
15 December 2025
·
STMicroelectronics (STM) Stock News and Forecasts: Starlink Chips, €1B EIB Funding, and What to Watch Into 2026 (Dec. 15, 2025)

STMicroelectronics (STM) Stock News and Forecasts: Starlink Chips, €1B EIB Funding, and What to Watch Into 2026 (Dec. 15, 2025)

STMicroelectronics N.V. stock (NYSE: STM, Euronext Paris: STMPA) is back in the news on December 15, 2025, after the company and SpaceX highlighted a decade-long collaboration that has quietly become a meaningful growth story inside ST’s portfolio: the chips that help Starlink connect millions of users worldwide. Reuters+1 For investors, today’s headline matters for two reasons. First, it puts hard numbers around a large, scaling end-market (satellite broadband terminals) that fits ST’s strengths in specialized RF (radio-frequency) and mixed-signal technologies. Second, it arrives days after ST announced a €1 billion European Investment Bank (EIB) credit line aimed at accelerating R&D
15 December 2025
···
IREN Limited Stock (NASDAQ: IREN): Latest News, Financing Update, and Analyst Forecasts as of Dec. 15, 2025

IREN Limited Stock (NASDAQ: IREN): Latest News, Financing Update, and Analyst Forecasts as of Dec. 15, 2025

IREN Limited stock has become one of the market’s strangest (and most fascinating) shape-shifters: a business built in the crypto-mining era that’s now trying to become a serious supplier of AI compute—right when hyperscalers are scrambling for power, data centers, and NVIDIA GPUs. As of mid-December, investors are weighing two huge forces pulling in opposite directions: Below is what’s driving IREN stock right now, what the latest company updates say, and what analysts are forecasting as of December 15, 2025. What’s new for IREN stock on Dec. 15, 2025 There’s no fresh corporate press release dated Dec. 15 from IREN
15 December 2025
·
Tesla Stock (TSLA) News Today: Driverless Robotaxi Tests, Analyst Price Targets, and 2026 Forecasts (Dec. 15, 2025)

Tesla Stock (TSLA) News Today: Driverless Robotaxi Tests, Analyst Price Targets, and 2026 Forecasts (Dec. 15, 2025)

Tesla, Inc. (NASDAQ: TSLA) is back in the middle of the market’s favorite argument: is Tesla primarily an electric-vehicle company battling a slowing demand cycle—or an AI/autonomy platform on the verge of a step-change moment? As of the latest available quote, Tesla stock is around $458.96 after a strong prior session, with heavy trading volume and a wide daily range that underscores how quickly sentiment can swing when “robotaxi” and “Full Self-Driving” (FSD) are in the headlines. StockAnalysis What’s new on December 15, 2025 is not another abstract promise. It’s a tangible signal from Austin, Texas—plus fresh analyst positioning and
15 December 2025
···
NVIDIA Stock (NVDA) News Today: China H200 Export Shift, Blackwell Ramp, and Wall Street Forecasts (December 15, 2025)

NVIDIA Stock (NVDA) News Today: China H200 Export Shift, Blackwell Ramp, and Wall Street Forecasts (December 15, 2025)

December 15, 2025 — NVIDIA Corporation (NASDAQ: NVDA) is entering the new week with investors trying to price two realities at once: a still-blistering AI infrastructure buildout that keeps pushing NVIDIA’s data-center business to fresh records, and a renewed wave of “AI trade” volatility driven by geopolitics, regulation, and big-tech spending scrutiny. At the center of the current narrative is a major policy pivot: the Trump administration’s decision to allow exports of NVIDIA’s H200 AI chips to China under a framework that includes a 25% fee on such sales—an announcement that has already triggered political backlash in Washington and complicated
15 December 2025
··
Oriental Culture Holding LTD Stock (NASDAQ: OCG) in Free-Fall After $200M ATM Filing: News, Forecast Scenarios, and What to Watch (Dec. 15, 2025)

Oriental Culture Holding LTD Stock (NASDAQ: OCG) in Free-Fall After $200M ATM Filing: News, Forecast Scenarios, and What to Watch (Dec. 15, 2025)

Oriental Culture Holding LTD (NASDAQ: OCG) has become one of the most extreme volatility stories in the U.S. micro-cap market heading into December 15, 2025—with the stock swinging from multi-dollar highs to penny-stock territory in a matter of sessions. The move has not been subtle: OCG’s latest available pricing shows the shares around $0.22, after a session that included an intraday range from roughly $0.20 to above $4.00 and massive volume. StockAnalysis So what changed? The biggest hard-news catalyst in the public record is a new equity financing tool: a $200 million at-the-market (ATM) offering program tied to a freshly
15 December 2025
·
iRobot Corporation Stock (IRBT) in Focus: Chapter 11 Bankruptcy, Picea Buyout Plan, and What It Means for Shareholders (Dec. 15, 2025)

iRobot Corporation Stock (IRBT) in Focus: Chapter 11 Bankruptcy, Picea Buyout Plan, and What It Means for Shareholders (Dec. 15, 2025)

iRobot Corporation (NASDAQ: IRBT) — the Roomba robot vacuum pioneer that helped make “robots in the home” feel normal — is now at a make-or-break moment for investors. On December 14–15, 2025, the company announced it has entered a court-supervised, pre-packaged Chapter 11 bankruptcy process tied to a deal that would transfer ownership to its secured lender and primary contract manufacturer, Shenzhen PICEA Robotics (together with Santrum Hong Kong). PR Newswire+1 For IRBT stockholders, the headline isn’t just “bankruptcy.” It’s the line in iRobot’s own announcement that changes everything: the company expects common shareholders to receive no recovery if the
15 December 2025
···
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation stock is back in the spotlight on December 15, 2025, as the cannabis sector reacts to a fresh wave of reporting that President Donald Trump may soon move to ease federal marijuana restrictions—specifically by reclassifying cannabis as a Schedule III drug under U.S. law. In early European trading on Monday, Canopy Growth led the group, jumping as much as 17.9% and extending a dramatic rally from the prior session. Reuters For investors, traders, and anyone trying to separate “real policy catalyst” from “market caffeine,” the key story today is simple: CGC is moving hard because U.S. federal
15 December 2025
··
Fermi Inc Stock (FRMI) Hit by $150M Tenant Funding Exit: Latest News, Forecasts, and Analyst Targets as of Dec. 15, 2025

Fermi Inc Stock (FRMI) Hit by $150M Tenant Funding Exit: Latest News, Forecasts, and Analyst Targets as of Dec. 15, 2025

Fermi Inc. (NASDAQ & LSE: FRMI) is having the kind of month that separates “big idea” infrastructure stories from the cold reality of signed contracts and cash timing. The headline catalyst: a prospective first tenant for Fermi’s flagship Texas development, Project Matador, terminated an agreement that could have advanced up to $150 million toward construction costs—triggering a violent market reaction and a fresh round of debate about what FRMI is worth before meaningful revenue arrives. FT Markets+1 Below is what’s known right now (as of December 15, 2025), what analysts are forecasting, and what to watch next. What happened to
15 December 2025
·
Compass Group PLC Stock (CPG.L) News, Forecasts and Analysis on 15 December 2025: Vermaat Deal Cleared as Analysts Target a Rebound

Compass Group PLC Stock (CPG.L) News, Forecasts and Analysis on 15 December 2025: Vermaat Deal Cleared as Analysts Target a Rebound

London — Compass Group PLC (LSE: CPG), the world’s largest contract caterer, is back in the spotlight on 15 December 2025 as investors digest a mix of fresh deal momentum, supportive broker commentary, and a share price that has drifted toward the lower end of its 52‑week range. MarketScreener+2Investing.com+2 Compass Group shares were trading around 2,322p (£23.22) on Monday, only slightly lower on the session, after closing 2,324p on 12 December. Intraday pricing has been choppy but contained, with today’s range roughly 2,318p to 2,334p according to market data services. MarketScreener+1 Compass Group share price today: why CPG stock is
15 December 2025
··
Anglo American PLC Stock (AAL.L) Today: Teck Merger Milestones, Copper Outlook, Analyst Forecasts and Key Risks (15 December 2025)

Anglo American PLC Stock (AAL.L) Today: Teck Merger Milestones, Copper Outlook, Analyst Forecasts and Key Risks (15 December 2025)

Anglo American plc stock (LSE: AAL, ticker often shown as AAL.L) is trading in a market that’s trying to price two big things at once: a copper-heavy future shaped by a transformational merger with Teck Resources, and the very real execution risk that comes with mega-deals, regulatory scrutiny, and operational bottlenecks. In London trading on 15 December 2025, Anglo American shares hovered around the mid‑2,800p level (roughly £28–£29 per share), after a volatile stretch that included a sharp drop late last week. FT Markets+1 What matters for Anglo American stock right now Anglo American share price on 15 December 2025:
15 December 2025
····
British American Tobacco Stock News (BATS.L / BTI) on Dec. 15, 2025: Buyback Update, Dividend Dates, 2026 Forecast and Analyst Targets

British American Tobacco Stock News (BATS.L / BTI) on Dec. 15, 2025: Buyback Update, Dividend Dates, 2026 Forecast and Analyst Targets

December 15, 2025 British American Tobacco p.l.c. stock is back in focus for income investors and “defensive” equity watchers—because the story is doing that very tobacco-company thing where cash returns look comforting while regulatory and category disruption refuse to be ignored. As of Monday, Dec. 15, 2025, British American Tobacco (LSE: BATS) traded around 4,268p (£42.68), up on the day, after a volatile stretch driven by BAT’s full-year pre-close update, a fresh £1.3 billion buyback plan for FY2026, and renewed debate over U.S. vaping competition and illicit products. London South East Below is a complete, publication-ready roundup of today’s (15.12.2025)
15 December 2025
·
1 … 401 402 403 404 405 … 535

Stock Market Today

Amazon stock (AMZN) slides on $200 billion AI capex plan — what Wall Street watches next week

Amazon stock (AMZN) slides on $200 billion AI capex plan — what Wall Street watches next week

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company forecast 2026 capital spending would jump to $200 billion, up more than 50% from 2025. The drop came as the Dow closed above 50,000 for the first time. Amazon reported fourth-quarter net sales up 14% to $213.4 billion and operating income at $25 billion. Trading in Amazon was volatile, with 179 million shares changing hands.
Bitcoin price wobbles below $69,000 on weekend — what matters before Monday’s reopen

Bitcoin price wobbles below $69,000 on weekend — what matters before Monday’s reopen

7 February 2026
Bitcoin fell 1.1% to $68,917 Saturday after volatile trading, while Ether held near $2,036. U.S. spot bitcoin ETFs saw $330.7 million in net inflows on Feb. 6, reversing outflows the previous day. Strategy shares rebounded after hitting a low of $111.27 Thursday. Traders are watching Monday’s U.S. market open and the upcoming inflation report for direction.
Go toTop